Risk stratification in emergency patients by copeptin

Area of Science:

• Emergency Medicine
• Clinical Biochemistry
• Prognostic Biomarkers

Background:

• Rapid risk stratification is crucial in emergency medicine for informed clinical decisions.
• Identifying high-risk patients aids in treatment, resource allocation, and follow-up planning.
• This study investigated mortality prediction using plasma copeptin in unselected hospital admissions.

Purpose of the Study:

• To determine the association between plasma copeptin levels and short-, mid-, and long-term mortality.
• To evaluate copeptin as a prognostic biomarker in unselected admitted patients.
• To assess the utility of copeptin for risk stratification in emergency settings.

Main Methods:

• Included 1,320 patients over 40 years old admitted to an inner-city hospital.
• Collected plasma within 24 hours of admission for copeptin measurement.
• Followed patients for a median of 11.5 years to track mortality.

Main Results:

• Elevated copeptin was significantly associated with increased short-term (1-week, 3-month), mid-term (1-year), and long-term mortality (P <0.01).
• Multivariable analysis confirmed elevated copeptin as an independent predictor of mortality across all timeframes.
• Adjusted hazard ratios for elevated copeptin were 2.4 (3-month), 1.9 (1-year), and 1.4 (entire period).

Conclusions:

• Plasma copeptin is a strong predictor of mortality in unselected hospital admissions.
• Rapid copeptin measurement can aid emergency department disposition decisions.
• Copeptin serves as a valuable tool for mid- and long-term risk assessment in hospitalized patients.